Sarcoma, one of the rarest cancers in the world, makes up just 1% of all adult cancer diagnoses, but it is widely recognized ...

A phase 2a trial shows tigilanol tiglate achieves an 80% response rate in soft tissue sarcoma, offering hope for effective ...

Despite the absence of pain signals, post-operative opioids control tachycardia and hypertension, highlighting the unique ...

Positive data from Stage 1 of the Phase IIa clinical trial (QB46C-H07) evaluating QBiotics' small molecule, tigilanol tiglate in 11 (10 evaluable) patients with advanced Soft Tissue Sarcoma (STS ...

Moleculin Biotech, Inc. announced promising results from their Phase 1B/2 trial of Annamycin for treating soft tissue sarcoma lung metastases, showing a robust clinical benefit rate of 59.4% among ...

Moleculin Reports Positive Topline Efficacy Results from U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases (MB-107) ...

The MB-107 trial was a multi-center, open-label, single-arm monotherapy study that in Phase 1B determined the Maximum Tolerable Dose and Recommended Phase 2 Dose (“MTD”, “RP2D ...

A soft tissue sarcoma (STS) is a malignant tumor that starts in soft tissue such as muscle, deep skin tissues, cartilage, or fat. It often occurs as a lump in the arm, although it can happen anywhere.

One sign of a sarcoma could be a lump you can feel through your skin. Now what? The lump may or may not be painful. Say you sprain your arm or leg. Should you have a doctor see it? And how soon? Is ...

At 16, Eldiara Doucette felt arm pain. It was 1st sign of rare soft tissue cancer that led to amputation.

As per the National Cancer Institute, about 12,000 cases of soft tissue sarcomas and 3,000 cases of bone sarcomas are ...